Canada’s pharmacy sector holding strong
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Looking ahead to 2019, the pharmacy business is poised to be more disrupted than ever before.
January 7, 2019
Putting patients first and encouraging innovation
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. For much of 2018, capital markets for biotech investment were strong. Some 53 biotech companies went public with more than $5.
Making the Rx markets more competitive again
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. This past June, Secretary of Health and Human Services Alex Azar told the Senate Finance Committee, “We need a strong, robust generic market.
Making health care work better for patients
Editor’s note: This was part of CDR’s 2019 Pharmacy Outlook in the January 7 issue. Pharmacists are medication experts. Every day, they get to see the remarkable difference innovative treatments can make in their customers’ lives.
Vestar Capital Partners to take major stake in IRI
A new era has begun at IRI. Already a leading provider of big data, predictive analytics and insights that help clients grow their business, the company is now in an even better position to have an impact on the marketplace as a result of a new financial structure. Last month, IRI closed a
Value-based contracts provide promise and potential
There has been significant focus and attention paid to the issue of drug prices in the last few years. As Adam Fein, president of Pembroke Consulting Inc. and chief executive officer of Drug Channels Institute, has said, “Drugs are 12% of the costs, but 90% of the conversation.
Bartell’s stands apart among regional chains
Founded in 1890, Bartell Drugs has maintained a leading position in the greater Seattle market by staying close to local consumers and continually developing new ways of addressing their changing needs.
Chain Drug Review names Hartsig top merchant
Walgreens is continuing to transform its retail business, and one of the principal architects of the transformation is senior vice president and chief merchandising officer Joe Hartsig.
Branded prescription drug spend — A basic framework
Drug prices are a major target of patient groups and Congress, although drug spending makes up only 10% of the $3.3 trillion spent on U.S. health care in a year.
WBA tabs three global executives
Walgreens Boots Alliance (WBA) recently announced three global leadership appointments. Vineet Mehra will be joining WBA as global chief marketing officer. He will be based at corporate headquarters here and will report to WBA co-chief operating officers Ornella Barra and Alex Gourlay.
Walgreens and Verily boost chronic care
Walgreens Boots Alliance (WBA) and Verily, an Alphabet company, will be collaborating on multiple projects under a broad agreement aimed at improving health outcomes for patients with chronic conditions, while also lowering the cost of care.
Retailers receive gift of holiday sales growth
Robust sales from before Thanksgiving through Christmas gave retailers much to cheer about at the end of last year. Holiday sales increased 5.1% to more than $850 billion — the strongest growth in the past six years, according to Mastercard SpendingPulse. Online shopping saw a 19.
Digitally nudging patients can create a win-win
Editor’s note: The fourth in a series of seven articles by A.T. Kearney on the trends that are radically transforming the health sector. By Todd Huseby and Carol Cruickshank Traditionally, the approach to health in the United States has been reactive or at best responsive.
To fix a broken system, put politics aside
The law of the land for almost a decade, the Patient Protection and Affordable Care Act of 2010 is as controversial now as it was when it was enacted.
Merlo is Health Care Executive of the Year
The combination of CVS Health and Aetna marks a new era in U.S. health care.